“Stopping the itch”: mass drug administration for scabies outbreak control covered for over nine million people in Ethiopia

  • Wendemagegn Enbiale Bahir Dar University, Bahir Dar, Ethiopia
  • Tariku Belachew Baynie Amhara Regional Health Bureau, Bahir Dar, Ethiopia
  • Ashenafie Ayalew Amhara Regional Health Bureau, Bahir Dar, Ethiopia
  • Tekilehayimanot Gebrehiwot Amhara Public Health Institute, Bahir Dar, Ethiopia
  • Tesfa Getanew Amhara Public Health Institute, Bahir Dar, Ethiopia
  • Alie Ayal Amhara Public Health Institute, Bahir Dar, Ethiopia
  • Misganaw Ayalew Amhara Public Health Institute, Bahir Dar, Ethiopia
  • Henry JC de Vries Amsterdam UMC, University of Amsterdam, department of dermatology, Amsterdam Institute for Infection and Immunity (AI and II), Amsterdam, Netherlands
  • Kuda Takarinda Center for Operational Research, International Union Against Tuberculosis and Lung Disease, Paris, France
  • Marcel Manzi Médecins Sans Frontierès-Luxembourg, LuxOR, Luxembourg city, Luxembourg
  • Rony Zachriah UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR), World Health Organization, Geneva, Switzerland
Keywords: Operational research, population based prevalence, community health workers, mass drug administration

Abstract

Introduction: In 2018, the Ethiopian Ministry of Health embarked on a Mass Drug Administration (MDA) campaign that involved over 9 million people in Ethiopia – the largest scabies MDA campaign ever conducted on a global level. We describe its implementation and report on a) numbers screened and identified with scabies, b) treatment category and drug type and c) human resources used, duration, and cost of the campaign.

Methodology: The MDA campaign was conducted according to national guidelines and activities including: planning and organization, engagement of local leaders, community mobilisation and advocacy, awareness-raising among health workers, field implementation, and monitoring and evaluation. The campaign was conducted between July and August 2018.

Results: The MDA campaign was implemented by about 15,000 people, mostly from the community, over an average of 6 days and reached 9, 057, 427 people. A total of 875,890 (9.7%) scabies cases were detected and 995,471 (11.0%) contacts received treatment. (Contact-to-case ratio = 1.3). Scabies prevalence varied, the highest prevalence was seen in Central Gondar (39.2%), South Gondar (16.7%) and North Gondar (15.0%), these neighbouring zones contributing more than two third of all scabies cases in the region. Of 1,738,304 (93%) who received treatment, 94% received ivermectin, the rest topical permethrin and sulfur. The average coverage capacity of an MDA campaign staff member was 84 people per day. The total cost was 11,696,333 United States Dollars (USD). Cost per 100,000 population = 129,135 USD.

Conclusions: This experience of rapid-large scale implementation would be useful to scale up similar interventions and “stop the itch” in other regions of Ethiopia.

Author Biography

Tesfa Getanew, Amhara Public Health Institute, Bahir Dar, Ethiopia

He was involved in the data collection and analysis. He has read the manuscript and approved the submission 

Published
2020-06-30
How to Cite
1.
Enbiale W, Baynie TB, Ayalew A, Gebrehiwot T, Getanew T, Ayal A, Ayalew M, de Vries HJ, Takarinda K, Manzi M, Zachriah R (2020) “Stopping the itch”: mass drug administration for scabies outbreak control covered for over nine million people in Ethiopia. J Infect Dev Ctries 14:28S-35S. doi: 10.3855/jidc.11701
Section
The Ethiopian SORT IT Course